# US 2003/0211144 A1 · Water-insoluble drug delivery system

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2003/0211144 A1
- Document ID: US20030211144A1
- Status: Published application
- Kind: A1
- Application number: 10/455,295
- Filed: 2003-06-05
- Published: 2003-11-13
- Earliest claimed: 1998-12-22
- Assignees: The Government of the USA, as represented by the Secretary, Department of Health and Human Services
- Inventors: S. Esmail Tabibi; Emmanuel I. Ezennia; B. Rao Vishnuvajjala; Shanker Gupta
- Web page: https://patentgrep.com/patent/US20030211144A1

## CPC

- A61K 31/4196: 1,2,4-Triazoles
- A61K 9/0019: {Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner (non-active ingredients are additionally classified in A61K47/00)}
- A61K 9/1075: {Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers (A61K9/0026 takes precedence)}
- A61K 9/127: Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K 31/33: Heterocyclic compounds
- A61K 31/4192: 1,2,3-Triazoles
- A61K 47/10: Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A61K 47/18: Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K 47/20: containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
- A61K 9/1278: Post-loading, e.g. by ion or pH gradient
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

The present invention provides a drug delivery system comprising a water-insoluble drug, a water-miscible organic solvent for the water-insoluble drug, a surfactant, and water, as well as a process for preparing the same. This invention further provides a pharmaceutical composition comprising a pharmaceutically acceptable carrier and such a drug delivery system. In addition, the present invention provides a method of delivering a drug to a host by administering to the host the drug delivery system of the present invention.

## Claims

### Claim 1

A drug delivery system comprising
(a) a water-insoluble drug,
(b) a water-miscible organic solvent for said water-insoluble drug,
(c) a surfactant, and
(d) water,
wherein said water-insoluble drug is dissolved in said water-insoluble organic solvent that forms a continuous phase with said water that contains said surfactant.

### Claim 2 (depends on 1)

The drug delivery system of claim 1, wherein said water-insoluble drug is at least one of the group consisting of an anticancer drug, an antitumor drug, an antihypertension drug, and an antibiotic drug.

### Claim 3 (depends on 1)

The drug delivery system of claim 1, wherein said water-insoluble drug is 17-allylaminogeldanamycin.

### Claim 4 (depends on 1)

The drug delivery system of claim 1, wherein said water-insoluble drug is carboxyamidotriazole.

### Claim 5 (depends on 1, 2, 3, 4)

The drug delivery system of any of claims 1-4, wherein said water-miscible organic solvent is selected from the group consisting of dimethylformamide, ethanol, glycerine, propylene glycol, and polyethylene glycol.

### Claim 6 (depends on 1, 2, 3, 4)

The drug delivery system of any of claims 1-4, wherein said water-miscible organic solvent is dimethlylsulfoxide.

### Claim 7 (depends on 1, 2, 3, 4)

The drug delivery system of any of claims 1-4, wherein said water-miscible organic solvent is dimethylacetamide.

### Claim 8 (depends on 1, 2, 3, 4, 5, 6, 7)

The drug delivery system of any of claims 1-7, further comprising an isotonizing agent.

### Claim 9 (depends on 1, 2, 3, 4, 5, 6, 7, 8)

The drug delivery system of any of claims 1-8, wherein said surfactant forms vesicles having an average particle size of about 50-200 nm.

### Claim 10 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9)

A pharmaceutical composition comprising a pharmaceutically acceptable carrier and said drug delivery system of any of claims 1-9.

### Claim 11 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9)

A method of delivering a drug to a host comprising administering the drug delivery system of any of claims 1-9 to said host.

### Claim 12 (depends on 11)

The method of claim 11, wherein said drug delivery system is administered in a therapeutically or prophylactically effective amount.

### Claim 13

A process for the preparation of a drug delivery system comprising
(a) providing a drug solution comprising a water-insoluble drug and a water-miscible organic solvent for said water-insoluble drug,
(b) providing a surfactant solution comprising a surfactant and water, and
(c) combining said drug solution and said surfactant solution to provide a drug delivery system.

### Claim 14 (depends on 13)

The process of claim 13, wherein said water-insoluble drug is at least one of the group consisting of an anticancer drug, an antitumor drug, an antihypertension drug, and an antibiotic drug.

### Claim 15 (depends on 13)

The process of claim 13, wherein said water-insoluble drug is 17-aminoallylgeldanamycin.

### Claim 16 (depends on 13)

The process of claim 13, wherein said water-insoluble drug is carboxyamidotriazole.

### Claim 17 (depends on 13, 14, 15, 16)

The process of any of claims 13-16, wherein said water-miscible organic solvent is selected from the group consisting of dimethylformamide, ethanol, glycerine, propylene glycol, and polyethylene glycol.

### Claim 18 (depends on 13, 14, 15, 16)

The process of any of claims 13-16, wherein said water-miscible organic solvent is dimethlylsulfoxide.

### Claim 19 (depends on 13, 14, 15, 16)

The process of any of claims 13-16, wherein said water-miscible organic solvent is dimethylacetamide.

### Claim 20 (depends on 13, 14, 15, 16, 17, 18, 19)

The process of any of claims 13-19, wherein said surfactant solution further comprises an isotonizing agent.

### Claim 21 (depends on 13, 14, 15, 16, 17, 18, 19, 20)

The process of any of claims 13-20, wherein said surfactant solution is processed by a high speed mixing device prior to combination with said drug solution.
